Glenmark Pharmaceuticals Ltd., incorporated in the year 1977 ... Company has reported net profit after tax of Rs 354.49 Crore in latest quarter.The company’s top management includes Mr.Glenn Saldanha, ...
At home, most sectors and themes are expensive compared to their recent historical averages. Banks and other lenders are considered the cheapest following their recent underperformance.
Alivus Life Sciences, formerly Glenmark, plans to invest in R&D, expand globally, and drive growth with new platforms.
BioCryst Pharmaceuticals, Inc. (BCRX) stock price is 7.33 and BioCryst Pharmaceuticals, Inc. (BCRX) 10-day simple moving average is 7.67. BioCryst Pharmaceuticals, Inc. (BCRX) stock price is 7.33 ...
Mirum Pharmaceuticals, Inc. (MIRM) stock price is 46.95 and Mirum Pharmaceuticals, Inc. (MIRM) 10-day simple moving average is 43.28. Mirum Pharmaceuticals, Inc. (MIRM) stock price is 46.95 and ...
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison. Important Information Please note the value of investments ...
and streamline your search for investment opportunities using Tipranks' Stock Screener Ed Arce’s rating is based on Mirum Pharmaceuticals’ impressive financial performance and strategic growth ...
The preliminary financial results for FY24 showcase a strong performance ... s confidence in recommending a Buy rating for Mirum Pharmaceuticals. In another report released on January 13, JMP ...
Facebook parent Meta on Tuesday announced that it's planning to cut back its workforce with the reductions focused on the lowest performers, according to an internal memo sent to Meta employees.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison. Important Information Please note the value of investments ...
RALEIGH, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, has partnered with USSM, an ...
Akums Drugs and Pharmaceuticals reported its fiscal Q1 earnings with a profit of Rs 61.21 crore in comparison to a loss of Rs 187.43 crore recorded during the corresponding quarter of the previous ...